The development of GMP manufactured Cas9 protein for therapeutic applications скачать в хорошем качестве

The development of GMP manufactured Cas9 protein for therapeutic applications

Presented By: Pandhita Pochanard Speaker Biography: Pandhita Pochanard is the product manager for Genome Editing portfolio at Thermo Fisher Scientific where she is directly responsible for the identification and development of novel genome editing technologies. Webinar: The development of GMP-manufactured Cas9 protein for therapeutic applications Webinar Abstract: CRISPR-Cas9 is one of the most commonly leveraged non-viral editing tools to engineer cells for therapeutics applications. It is a nuclease-based genome editing system which has seen exponential growth in adoption for cell therapy development. To move your work from research through clinical trials and commercialization, access to GMP-grade CRISPR-Cas9 reagents that can meet your clinical needs and required regulatory standards is critical. In this presentation, we will explore the development of a GMP-grade Cas9 protein suitable for cell therapy applications. Then, we will focus on the manufacturing process controls and quality specifications needed to help ensure compliance to the appropriate regulatory standards. Finally, we will showcase its application in a T-cell workflow. Earn PACE Credits: (Delete this if the webinar doesn’t offer PACE) 1. Make sure you're a registered member of LabRoots (Link to Microsite) 2. Watch the webinar on the LabRoots Website (Link to Microsite) 3. Click Here to get your PACE credits (Expiration date – 2 years webinar date): (PACE Link) This link will be located in the CMS in the webinar CE tab – please enable third party PACE link LabRoots on Social: Facebook:   / labrootsinc   Twitter:   / labroots   LinkedIn:   / labroots   Instagram:   / labrootsinc   Pinterest:   / labroots   SnapChat: labroots_inc